This inventor holds 1 USPTO granted patent. Top assignee: Tianjin University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Zhiqun Shang: Innovator in Theranostic Probes
Introduction
Zhiqun Shang is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of biomedical engineering, particularly in the development of theranostic probes. His work focuses on enhancing targeted therapies for cancer treatment.
Latest Patents
Zhiqun Shang holds a patent titled "A Theranostic Probe and its Use for Targeting and/or Labeling the EGFR Kinase and/or the Cells Expressing EGFR or its Family Members." This innovative probe aims to improve the precision of cancer therapies by targeting specific proteins associated with tumor growth.
Career Highlights
Zhiqun Shang is affiliated with Tianjin University, where he conducts research and develops new technologies in the field of medical diagnostics. His expertise in theranostics has positioned him as a leader in this emerging area of study.
Collaborations
Zhiqun Shang has collaborated with notable colleagues, including Xiaohong Qin and Lizhi Mi, who contribute to his research efforts and advancements in theranostic applications.
Conclusion
Zhiqun Shang's innovative work in theranostic probes represents a significant advancement in targeted cancer therapies. His contributions continue to influence the field and pave the way for future developments in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile